Home › Funds › Winning Points Advisors, LLC › IBRX
Winning Points Advisors, LLC position in IBRX
IMMUNITYBIO INC · Health Care
Winning Points Advisors, LLC reported holding 726,258 shares of IBRX (IMMUNITYBIO INC) in its Q2 2026 13F filing — a position valued at US$2.3M, representing 3.01% of its reported portfolio and ranking #7 among its reported holdings. Winning Points Advisors, LLC has disclosed IBRX holdings in 4 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Winning Points Advisors, LLC's IBRX position evolved
Winning Points Advisors, LLC first disclosed a stake in IBRX in Q3 2024 at 89,396 shares (US$143K). The position peaked in Q1 2026 at 723,573 shares, worth US$5.3M. Across 4 filings, Winning Points Advisors, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 726,258 shares valued at US$2.3M. Notable position changes include a 708% increase in Q4 2025 (shares rose 287% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 89.40K | $143.03K | New |
| Q4 2025 | 722.37K | $509.00K | Add |
| Q1 2026 | 723.57K | $5.32M | Hold |
| Q2 2026 | 726.26K | $2.29M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IBRX and 13F data
IBRX (IMMUNITYBIO INC) is a Health Care company. 69 other funds we track also report a position in IBRX — the largest reported positions include GREAT POINT PARTNERS LLC (US$26.3M), VESTOR CAPITAL, LLC (US$12.1M), Sound Capital Solutions LLC (US$9.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IBRX
- GREAT POINT PARTNERS LLC 3.00M sh · $26.27M · Q2 2026
- VESTOR CAPITAL, LLC 44.84K sh · $12.05M · Q2 2026
- Sound Capital Solutions LLC 1.12M sh · $9.81M · Q2 2026
- Clearwater Capital Advisors, LLC 717.52K sh · $6.28M · Q2 2026
- ALLEN HOLDING INC /NY 687.57K sh · $6.02M · Q2 2026
- Kercheville Advisors, LLC 613.38K sh · $5.79M · Q3 2026
- SHEETS SMITH WEALTH MANAGEMENT 512.57K sh · $4.84M · Q3 2026
- Legacy Capital Group California, Inc. 446.00K sh · $3.90M · Q2 2026
- MOR Wealth Management, LLC 302.45K sh · $2.65M · Q2 2026
- NIA IMPACT ADVISORS, LLC 270.17K sh · $2.37M · Q2 2026
More on Winning Points Advisors, LLC
FAQ
How long has Winning Points Advisors, LLC held IBRX?
Winning Points Advisors, LLC has disclosed IBRX holdings in 4 of the last 8 reported quarters, going back to Q3 2024.
What is Winning Points Advisors, LLC's current position in IBRX?
As of Q2 2026, Winning Points Advisors, LLC holds 726.26K shares of IBRX (IMMUNITYBIO INC), valued at $2.29M, representing 3.01% of its reported portfolio and ranking #7.
Has Winning Points Advisors, LLC been buying or selling IBRX?
In the latest 13F filing (Q2 2026), Winning Points Advisors, LLC held unchanged its position in IBRX. The position peaked in Q1 2026 at 723.57K shares.
Which other funds hold IBRX?
Other major institutional holders of IBRX include GREAT POINT PARTNERS LLC, VESTOR CAPITAL, LLC, Sound Capital Solutions LLC, among 69 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.